EGFR, ALK, ROS1, PG-L1 in Israel — 3 passende Kliniken mit Kosten erhalten

Lung cancer molecular profiling in Israel typically costs from $1,500 to $2,500. The price depends on the testing method like IHC or NGS. Clinics in Tel Aviv and Haifa provide these tests for international patients. In the US, average costs are around $2,400. Patients in Israel save approximately 38% compared to US prices.

• Next-generation sequencing: This method provides a broader genetic map of the tumor. It often costs more than single-gene tests like IHC.
• City variations: Testing in Tel Aviv facilities may cost 10-15% more than in Haifa. Private medical centers typically charge higher rates than public hospitals.
• Biopsy processing fees: Costs vary if the lab uses existing tissue or needs new samples. New biopsies add surgical and pathology fees to the total.
• Immune-histochemistry (IHC): This technique identifies specific proteins on the cell surface. It is the most common way to test for PD-L1 levels.

Bookimed Expert Insight: Genetic testing in Israel offers unique value through access to globally recognized oncology experts. Dr. Ofer Merimsky at Sourasky Medical Center is a leader in lung cancer research. He uses molecular profiles to select targeted therapies or immunotherapy for his patients. Rambam Medical Center in Haifa also provides top-tier diagnostics and holds Joint Commission International accreditation. This hospital treats nearly one million patients every year with modern laboratory equipment. Choosing these centers allows for precise treatment plans based on the latest scientific data.